Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous and Allogeneic”

142 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 142 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05261750
What this trial is testing

Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
PT. Prodia Stem Cell Indonesia 15
Testing effectiveness (Phase 2)WithdrawnNCT00728585
What this trial is testing

Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant

Who this might be right for
Gastrointestinal MucositisMalignant Neoplasm
Children's Oncology Group
Not applicableLooking for participantsNCT01166009
What this trial is testing

CIBMTR Research Database

Who this might be right for
Autologous Stem Cell TransplantationAllogeneic Stem Cell TransplantationSolid Tumors+4 more
Center for International Blood and Marrow Transplant Research 99,999,999
Post-approval studies (Phase 4)UnknownNCT00199147
What this trial is testing

Efficacy of G-CSF-Priming in Elderly AML Patients

Who this might be right for
Acute Myeloid Leukemia
Johann Wolfgang Goethe University Hospital 250
Testing effectiveness (Phase 2)Study completedNCT00002552
What this trial is testing

Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT01605383
What this trial is testing

Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head

Who this might be right for
Avascular Necrosis of Femur Head
Banc de Sang i Teixits 23
Large-scale testing (Phase 3)Active Not RecruitingNCT06149403
What this trial is testing

Investigate the Efficacy and Safety of OTL-203 in Subjects With MPS-IH Compared With Standard of Care With Allogeneic HSCT

Who this might be right for
MPS-IH (Hurler Syndrome)
Orchard Therapeutics 41
Testing effectiveness (Phase 2)Ended earlyNCT00121186
What this trial is testing

S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 1
Early research (Phase 1)Study completedNCT00002787
What this trial is testing

Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 22
Testing effectiveness (Phase 2)Looking for participantsNCT00722228
What this trial is testing

Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors

Who this might be right for
Colorectal CancerOvarian CancerGastric Cancer+4 more
Hadassah Medical Organization 50
Testing effectiveness (Phase 2)Study completedNCT00003954
What this trial is testing

Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Fred Hutchinson Cancer Center 40
Not applicableUnknownNCT01491230
What this trial is testing

Neutrophil Extracellular Traps Formation Post-hematopoietic Stem Cell Transplantation

Who this might be right for
Childhood Cancer
Tel-Aviv Sourasky Medical Center 50
Post-approval studies (Phase 4)Study completedNCT00180102
What this trial is testing

AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years

Who this might be right for
Leukemia, Nonlymphocytic, Acute
Technische Universität Dresden 600
Testing effectiveness (Phase 2)Study completedNCT00781170
What this trial is testing

Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaStem Cell Transplantation
Universitätsklinikum Hamburg-Eppendorf 20
Testing effectiveness (Phase 2)Study completedNCT00899847
What this trial is testing

Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

Who this might be right for
Transplantation, HomologousTransplantation, AutologousMultiple Myeloma+1 more
Stanford University 9
Early research (Phase 1)Study completedNCT03158896
What this trial is testing

Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease

Who this might be right for
Acute Graft Versus Host Disease
University of Kansas Medical Center 24
Testing effectiveness (Phase 2)Ended earlyNCT01773395
What this trial is testing

GVAX vs. Placebo for MDS/AML After Allo HSCT

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Dana-Farber Cancer Institute 123
Not applicableStudy completedNCT00558948
What this trial is testing

Musculoskeletal Outcomes After Bone Marrow Transplant

Who this might be right for
Survivors of Bone Marrow TransplantAutologous and Allogeneic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Not applicableLooking for participantsNCT07253129
What this trial is testing

Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 88
Large-scale testing (Phase 3)UnknownNCT00998270
What this trial is testing

Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Tehran University of Medical Sciences 185
Load More Results